🇺🇸 Ticagrelor Tablets in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 5

Most-reported reactions

1. Blood Uric Acid Increased — 1 report (20%)
2. Chest Discomfort — 1 report (20%)
3. Chest Pain — 1 report (20%)
4. Dyspnoea — 1 report (20%)
5. Haemorrhage Intracranial — 1 report (20%)

Source database →

Frequently asked questions

Is Ticagrelor Tablets approved in United States?

Ticagrelor Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ticagrelor Tablets in United States?

Advenchen Laboratories Nanjing Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.